Teaching Experience: Pharmaceutical Market to Fight Against Covid-19
Cristina Vilaplana-Prieto University of Murcia
Abstract
As the Sars-CoV2 pandemic continues to grow, researchers around the world are urgently seeking new treatments to prevent infection, cure those infected, or lessen the severity of the disease. As of 9 January 2021, 87.5 million cases have been confirmed and 1.9 million people have died. Although there are several recently approved vaccines, clinical trials are
underway to "re-use" drugs normally indicated for other diseases (Li and LeClercq, 2020). The shorter development time and reduced costs of using existing compounds are particularly advantageous compared to the discovery of new drugs in a pandemic situation, where time is of the essence.